Mov Disord 35:2033 Harada N, Kanayama M, Maruyama A, Yoshida A, Tazumi K, Hosoya T, Mimura J, Toki T, Maher JM, Yamamoto M, Itoh K (2011) Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages
Real-world use often extends beyond this timeframe, with many individuals maintaining therapy for years
Currently, the NRF2-regulated antioxidant system is emerging as a critical player in the context of OSA, becoming dysregulated due to IH and elevated levels of ROS
Early-phase studies report reductions in food and substance cravings, though more research is needed to validate these outcomes in broader populations
What is HGH (Somatropin)